nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Temozolomide—malignant glioma	0.142	1	CbGbCtD
Fulvestrant—NR1H4—skull—malignant glioma	0.064	0.364	CbGeAlD
Fulvestrant—EPHX2—retina—malignant glioma	0.0122	0.0693	CbGeAlD
Fulvestrant—ESR1—blood vessel—malignant glioma	0.00833	0.0473	CbGeAlD
Fulvestrant—Digestion impaired—Temozolomide—malignant glioma	0.00779	0.0331	CcSEcCtD
Fulvestrant—ESRRA—medulla oblongata—malignant glioma	0.00773	0.0439	CbGeAlD
Fulvestrant—ESRRA—midbrain—malignant glioma	0.00706	0.0401	CbGeAlD
Fulvestrant—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00704	0.0299	CcSEcCtD
Fulvestrant—ESRRA—spinal cord—malignant glioma	0.00689	0.0391	CbGeAlD
Fulvestrant—ESR2—brainstem—malignant glioma	0.00665	0.0378	CbGeAlD
Fulvestrant—Injection site pain—Carmustine—malignant glioma	0.0066	0.028	CcSEcCtD
Fulvestrant—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00633	0.0269	CcSEcCtD
Fulvestrant—EPHX2—cerebellum—malignant glioma	0.00624	0.0354	CbGeAlD
Fulvestrant—Accidental injury—Carmustine—malignant glioma	0.00609	0.0259	CcSEcCtD
Fulvestrant—ESR2—telencephalon—malignant glioma	0.0059	0.0335	CbGeAlD
Fulvestrant—ESRRA—central nervous system—malignant glioma	0.00559	0.0317	CbGeAlD
Fulvestrant—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00551	0.0234	CcSEcCtD
Fulvestrant—ESRRA—cerebellum—malignant glioma	0.00546	0.031	CbGeAlD
Fulvestrant—Injection site reaction—Carmustine—malignant glioma	0.00536	0.0227	CcSEcCtD
Fulvestrant—Musculoskeletal pain—Temozolomide—malignant glioma	0.00527	0.0224	CcSEcCtD
Fulvestrant—EPHX2—brain—malignant glioma	0.00507	0.0288	CbGeAlD
Fulvestrant—ESR1—embryo—malignant glioma	0.00497	0.0282	CbGeAlD
Fulvestrant—ESR1—brainstem—malignant glioma	0.00456	0.0259	CbGeAlD
Fulvestrant—ESRRA—brain—malignant glioma	0.00444	0.0252	CbGeAlD
Fulvestrant—Injury—Carmustine—malignant glioma	0.00426	0.0181	CcSEcCtD
Fulvestrant—Hepatic failure—Temozolomide—malignant glioma	0.00421	0.0179	CcSEcCtD
Fulvestrant—Hot flush—Temozolomide—malignant glioma	0.00404	0.0172	CcSEcCtD
Fulvestrant—ESR1—telencephalon—malignant glioma	0.00404	0.023	CbGeAlD
Fulvestrant—Menopausal symptoms—Temozolomide—malignant glioma	0.00401	0.017	CcSEcCtD
Fulvestrant—Breast disorder—Temozolomide—malignant glioma	0.00342	0.0145	CcSEcCtD
Fulvestrant—ESR2—central nervous system—malignant glioma	0.00335	0.0191	CbGeAlD
Fulvestrant—ESR2—cerebellum—malignant glioma	0.00328	0.0186	CbGeAlD
Fulvestrant—Depression—Carmustine—malignant glioma	0.00301	0.0128	CcSEcCtD
Fulvestrant—Urinary tract infection—Carmustine—malignant glioma	0.00293	0.0124	CcSEcCtD
Fulvestrant—Infestation NOS—Temozolomide—malignant glioma	0.00291	0.0124	CcSEcCtD
Fulvestrant—Infestation—Temozolomide—malignant glioma	0.00291	0.0124	CcSEcCtD
Fulvestrant—Depression—Temozolomide—malignant glioma	0.00291	0.0123	CcSEcCtD
Fulvestrant—Urinary tract infection—Temozolomide—malignant glioma	0.00283	0.012	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Temozolomide—malignant glioma	0.00276	0.0117	CcSEcCtD
Fulvestrant—Haemoglobin—Carmustine—malignant glioma	0.00272	0.0115	CcSEcCtD
Fulvestrant—Haemorrhage—Carmustine—malignant glioma	0.00271	0.0115	CcSEcCtD
Fulvestrant—Oedema peripheral—Carmustine—malignant glioma	0.00267	0.0113	CcSEcCtD
Fulvestrant—ESR2—brain—malignant glioma	0.00266	0.0151	CbGeAlD
Fulvestrant—Connective tissue disorder—Carmustine—malignant glioma	0.00266	0.0113	CcSEcCtD
Fulvestrant—Haemoglobin—Temozolomide—malignant glioma	0.00263	0.0112	CcSEcCtD
Fulvestrant—Haemorrhage—Temozolomide—malignant glioma	0.00262	0.0111	CcSEcCtD
Fulvestrant—Hepatitis—Temozolomide—malignant glioma	0.00262	0.0111	CcSEcCtD
Fulvestrant—Pharyngitis—Temozolomide—malignant glioma	0.0026	0.011	CcSEcCtD
Fulvestrant—Oedema peripheral—Temozolomide—malignant glioma	0.00258	0.0109	CcSEcCtD
Fulvestrant—Connective tissue disorder—Temozolomide—malignant glioma	0.00257	0.0109	CcSEcCtD
Fulvestrant—Angiopathy—Temozolomide—malignant glioma	0.00237	0.0101	CcSEcCtD
Fulvestrant—Immune system disorder—Temozolomide—malignant glioma	0.00236	0.01	CcSEcCtD
Fulvestrant—Malnutrition—Carmustine—malignant glioma	0.00236	0.01	CcSEcCtD
Fulvestrant—ESR1—central nervous system—malignant glioma	0.0023	0.0131	CbGeAlD
Fulvestrant—Back pain—Carmustine—malignant glioma	0.00228	0.00967	CcSEcCtD
Fulvestrant—Malnutrition—Temozolomide—malignant glioma	0.00228	0.00966	CcSEcCtD
Fulvestrant—ESR1—cerebellum—malignant glioma	0.00225	0.0128	CbGeAlD
Fulvestrant—Back pain—Temozolomide—malignant glioma	0.0022	0.00935	CcSEcCtD
Fulvestrant—Anaemia—Carmustine—malignant glioma	0.00218	0.00924	CcSEcCtD
Fulvestrant—Leukopenia—Carmustine—malignant glioma	0.00211	0.00895	CcSEcCtD
Fulvestrant—Anaemia—Temozolomide—malignant glioma	0.00211	0.00893	CcSEcCtD
Fulvestrant—Angioedema—Temozolomide—malignant glioma	0.00208	0.00883	CcSEcCtD
Fulvestrant—Vertigo—Temozolomide—malignant glioma	0.00205	0.00868	CcSEcCtD
Fulvestrant—Leukopenia—Temozolomide—malignant glioma	0.00204	0.00865	CcSEcCtD
Fulvestrant—Myalgia—Carmustine—malignant glioma	0.00201	0.00851	CcSEcCtD
Fulvestrant—Chest pain—Carmustine—malignant glioma	0.00201	0.00851	CcSEcCtD
Fulvestrant—Anxiety—Carmustine—malignant glioma	0.002	0.00849	CcSEcCtD
Fulvestrant—Cough—Temozolomide—malignant glioma	0.00199	0.00843	CcSEcCtD
Fulvestrant—Myalgia—Temozolomide—malignant glioma	0.00194	0.00823	CcSEcCtD
Fulvestrant—Arthralgia—Temozolomide—malignant glioma	0.00194	0.00823	CcSEcCtD
Fulvestrant—Anxiety—Temozolomide—malignant glioma	0.00193	0.0082	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00193	0.00817	CcSEcCtD
Fulvestrant—Infection—Carmustine—malignant glioma	0.00191	0.00811	CcSEcCtD
Fulvestrant—Infection—Temozolomide—malignant glioma	0.00185	0.00784	CcSEcCtD
Fulvestrant—Anorexia—Carmustine—malignant glioma	0.00183	0.00778	CcSEcCtD
Fulvestrant—ESR1—brain—malignant glioma	0.00182	0.0104	CbGeAlD
Fulvestrant—Nervous system disorder—Temozolomide—malignant glioma	0.00182	0.00774	CcSEcCtD
Fulvestrant—Skin disorder—Temozolomide—malignant glioma	0.00181	0.00766	CcSEcCtD
Fulvestrant—Hyperhidrosis—Temozolomide—malignant glioma	0.0018	0.00763	CcSEcCtD
Fulvestrant—Anorexia—Temozolomide—malignant glioma	0.00177	0.00752	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00175	0.00744	CcSEcCtD
Fulvestrant—Insomnia—Carmustine—malignant glioma	0.00174	0.00738	CcSEcCtD
Fulvestrant—Paraesthesia—Carmustine—malignant glioma	0.00173	0.00733	CcSEcCtD
Fulvestrant—Dyspnoea—Carmustine—malignant glioma	0.00171	0.00728	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00169	0.00719	CcSEcCtD
Fulvestrant—Insomnia—Temozolomide—malignant glioma	0.00168	0.00713	CcSEcCtD
Fulvestrant—Decreased appetite—Carmustine—malignant glioma	0.00167	0.0071	CcSEcCtD
Fulvestrant—Paraesthesia—Temozolomide—malignant glioma	0.00167	0.00708	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Carmustine—malignant glioma	0.00166	0.00705	CcSEcCtD
Fulvestrant—Dyspnoea—Temozolomide—malignant glioma	0.00166	0.00703	CcSEcCtD
Fulvestrant—Pain—Carmustine—malignant glioma	0.00164	0.00698	CcSEcCtD
Fulvestrant—Constipation—Carmustine—malignant glioma	0.00164	0.00698	CcSEcCtD
Fulvestrant—Dyspepsia—Temozolomide—malignant glioma	0.00164	0.00694	CcSEcCtD
Fulvestrant—Decreased appetite—Temozolomide—malignant glioma	0.00162	0.00686	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0016	0.00681	CcSEcCtD
Fulvestrant—Fatigue—Temozolomide—malignant glioma	0.0016	0.0068	CcSEcCtD
Fulvestrant—Constipation—Temozolomide—malignant glioma	0.00159	0.00675	CcSEcCtD
Fulvestrant—Pain—Temozolomide—malignant glioma	0.00159	0.00675	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Carmustine—malignant glioma	0.00157	0.00667	CcSEcCtD
Fulvestrant—Abdominal pain—Carmustine—malignant glioma	0.00152	0.00645	CcSEcCtD
Fulvestrant—Body temperature increased—Carmustine—malignant glioma	0.00152	0.00645	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Temozolomide—malignant glioma	0.00152	0.00645	CcSEcCtD
Fulvestrant—Urticaria—Temozolomide—malignant glioma	0.00148	0.00627	CcSEcCtD
Fulvestrant—Abdominal pain—Temozolomide—malignant glioma	0.00147	0.00624	CcSEcCtD
Fulvestrant—Body temperature increased—Temozolomide—malignant glioma	0.00147	0.00624	CcSEcCtD
Fulvestrant—Hypersensitivity—Carmustine—malignant glioma	0.00142	0.00601	CcSEcCtD
Fulvestrant—Asthenia—Carmustine—malignant glioma	0.00138	0.00586	CcSEcCtD
Fulvestrant—Hypersensitivity—Temozolomide—malignant glioma	0.00137	0.00581	CcSEcCtD
Fulvestrant—Asthenia—Temozolomide—malignant glioma	0.00133	0.00566	CcSEcCtD
Fulvestrant—Diarrhoea—Carmustine—malignant glioma	0.00132	0.00558	CcSEcCtD
Fulvestrant—Pruritus—Temozolomide—malignant glioma	0.00132	0.00558	CcSEcCtD
Fulvestrant—CYP3A4—central nervous system—malignant glioma	0.00128	0.00728	CbGeAlD
Fulvestrant—Dizziness—Carmustine—malignant glioma	0.00127	0.0054	CcSEcCtD
Fulvestrant—Diarrhoea—Temozolomide—malignant glioma	0.00127	0.0054	CcSEcCtD
Fulvestrant—Dizziness—Temozolomide—malignant glioma	0.00123	0.00522	CcSEcCtD
Fulvestrant—Vomiting—Carmustine—malignant glioma	0.00122	0.00519	CcSEcCtD
Fulvestrant—Rash—Carmustine—malignant glioma	0.00121	0.00515	CcSEcCtD
Fulvestrant—Dermatitis—Carmustine—malignant glioma	0.00121	0.00514	CcSEcCtD
Fulvestrant—Headache—Carmustine—malignant glioma	0.00121	0.00511	CcSEcCtD
Fulvestrant—Vomiting—Temozolomide—malignant glioma	0.00118	0.00502	CcSEcCtD
Fulvestrant—Rash—Temozolomide—malignant glioma	0.00117	0.00497	CcSEcCtD
Fulvestrant—Dermatitis—Temozolomide—malignant glioma	0.00117	0.00497	CcSEcCtD
Fulvestrant—Headache—Temozolomide—malignant glioma	0.00116	0.00494	CcSEcCtD
Fulvestrant—Nausea—Carmustine—malignant glioma	0.00114	0.00485	CcSEcCtD
Fulvestrant—Nausea—Temozolomide—malignant glioma	0.0011	0.00469	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—GSTP1—malignant glioma	0.000288	0.000645	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—CDKN2B—malignant glioma	0.000287	0.000642	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CD—malignant glioma	0.000286	0.00064	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SLC5A5—malignant glioma	0.000286	0.00064	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000286	0.00064	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000283	0.000634	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CAT—malignant glioma	0.00028	0.000627	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00028	0.000627	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000276	0.000617	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—FGF2—malignant glioma	0.000274	0.000613	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—malignant glioma	0.000273	0.000612	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000273	0.000612	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000273	0.000611	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NCOR1—malignant glioma	0.000272	0.000609	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH3—malignant glioma	0.000272	0.000609	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000271	0.000607	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00027	0.000605	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000268	0.0006	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000268	0.0006	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NCOR1—malignant glioma	0.000265	0.000592	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000261	0.000585	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000258	0.000577	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARG—malignant glioma	0.000258	0.000577	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.000258	0.000577	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MDM2—malignant glioma	0.000256	0.000574	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—RAF1—malignant glioma	0.000255	0.000572	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—ERBB2—malignant glioma	0.000253	0.000566	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—H3F3A—malignant glioma	0.000252	0.000565	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000251	0.000562	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000251	0.000562	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CB—malignant glioma	0.000249	0.000558	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000249	0.000557	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000248	0.000555	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000248	0.000555	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH2—malignant glioma	0.000244	0.000546	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000243	0.000544	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTT1—malignant glioma	0.000243	0.000543	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH3—malignant glioma	0.000237	0.00053	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—AKT1—malignant glioma	0.000236	0.000529	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LATS1—malignant glioma	0.000235	0.000527	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000234	0.000523	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MYC—malignant glioma	0.000231	0.000517	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000231	0.000516	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTP1—malignant glioma	0.00023	0.000515	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000228	0.000511	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS1—malignant glioma	0.000227	0.000509	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000227	0.000507	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CAT—malignant glioma	0.000224	0.000502	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000222	0.000498	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—AKT1—malignant glioma	0.000219	0.000489	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000217	0.000487	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000217	0.000485	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000217	0.000485	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CAV1—malignant glioma	0.000216	0.000483	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PTEN—malignant glioma	0.000215	0.000482	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000213	0.000478	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000213	0.000476	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH2—malignant glioma	0.000212	0.000475	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NCOR1—malignant glioma	0.000212	0.000474	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—BCHE—malignant glioma	0.000211	0.000473	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00021	0.000471	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—CDKN2B—malignant glioma	0.00021	0.000469	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC5A5—malignant glioma	0.000209	0.000468	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NOTCH1—malignant glioma	0.000207	0.000462	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000206	0.000461	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000206	0.000461	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000205	0.00046	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000205	0.000459	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000203	0.000455	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NCOR1—malignant glioma	0.000199	0.000445	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000198	0.000442	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CG—malignant glioma	0.000197	0.00044	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000196	0.000438	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000196	0.000438	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—malignant glioma	0.000195	0.000437	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000192	0.000431	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000191	0.000428	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000191	0.000428	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.00019	0.000426	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—malignant glioma	0.00019	0.000425	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—CDKN2B—malignant glioma	0.000183	0.000409	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000181	0.000406	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.00018	0.000403	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000179	0.000402	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000176	0.000394	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—malignant glioma	0.000175	0.000392	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NCOR1—malignant glioma	0.000173	0.000388	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CD—malignant glioma	0.000173	0.000387	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CAV1—malignant glioma	0.000172	0.000386	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000171	0.000382	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT3B—malignant glioma	0.000169	0.000379	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MYC—malignant glioma	0.000169	0.000378	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—malignant glioma	0.000168	0.000377	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000166	0.000372	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—KRAS—malignant glioma	0.000165	0.00037	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000165	0.000369	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HIST1H3B—malignant glioma	0.000165	0.000369	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAT—malignant glioma	0.000164	0.000366	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000162	0.000363	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MDK—malignant glioma	0.000159	0.000356	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CG—malignant glioma	0.000157	0.000352	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NCOR1—malignant glioma	0.000155	0.000346	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CA—malignant glioma	0.000152	0.00034	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DTX1—malignant glioma	0.000152	0.00034	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—malignant glioma	0.000152	0.000339	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NOTCH1—malignant glioma	0.000151	0.000338	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CB—malignant glioma	0.000151	0.000337	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—malignant glioma	0.000149	0.000334	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000149	0.000334	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000148	0.000331	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MYC—malignant glioma	0.000147	0.000329	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000146	0.000327	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—malignant glioma	0.000142	0.000319	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000142	0.000319	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000141	0.000315	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000139	0.000311	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000139	0.000311	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CD—malignant glioma	0.000138	0.000309	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000138	0.000309	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000138	0.000308	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NOTCH1—malignant glioma	0.000131	0.000294	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTEN—malignant glioma	0.00013	0.000291	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—malignant glioma	0.00013	0.000291	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—H3F3A—malignant glioma	0.000127	0.000285	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000127	0.000283	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAV1—malignant glioma	0.000126	0.000282	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000125	0.000279	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—malignant glioma	0.000124	0.000278	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—malignant glioma	0.000124	0.000278	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000122	0.000274	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SUFU—malignant glioma	0.00012	0.00027	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.00012	0.00027	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CB—malignant glioma	0.00012	0.000269	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH3—malignant glioma	0.000119	0.000267	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—malignant glioma	0.000119	0.000267	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HEY2—malignant glioma	0.000119	0.000266	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GFAP—malignant glioma	0.000116	0.00026	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CG—malignant glioma	0.000115	0.000257	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SPHK1—malignant glioma	0.000112	0.000252	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—malignant glioma	0.000111	0.000249	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—malignant glioma	0.000111	0.000248	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HEY1—malignant glioma	0.00011	0.000247	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR4—malignant glioma	0.00011	0.000247	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH2—malignant glioma	0.000107	0.00024	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000107	0.00024	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTEN—malignant glioma	0.000104	0.000233	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000103	0.000232	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CD—malignant glioma	0.000101	0.000226	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAG2—malignant glioma	9.77e-05	0.000219	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CDKN2B—malignant glioma	9.21e-05	0.000206	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—malignant glioma	9.18e-05	0.000205	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CB—malignant glioma	8.8e-05	0.000197	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NCOR1—malignant glioma	8.73e-05	0.000195	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—malignant glioma	8.72e-05	0.000195	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—H3F3A—malignant glioma	8.27e-05	0.000185	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCR3—malignant glioma	8.19e-05	0.000183	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COX8A—malignant glioma	8.18e-05	0.000183	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—malignant glioma	8.12e-05	0.000182	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NTRK2—malignant glioma	7.97e-05	0.000178	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—YWHAE—malignant glioma	7.97e-05	0.000178	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FLT1—malignant glioma	7.93e-05	0.000178	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DUSP6—malignant glioma	7.9e-05	0.000177	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAG1—malignant glioma	7.8e-05	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH3—malignant glioma	7.76e-05	0.000174	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—malignant glioma	7.71e-05	0.000173	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FBXW7—malignant glioma	7.64e-05	0.000171	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTEN—malignant glioma	7.6e-05	0.00017	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—malignant glioma	7.5e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BDKRB2—malignant glioma	7.49e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—malignant glioma	7.41e-05	0.000166	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—malignant glioma	7.34e-05	0.000164	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—malignant glioma	7.07e-05	0.000158	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH2—malignant glioma	6.96e-05	0.000156	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ASMT—malignant glioma	6.95e-05	0.000156	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KNG1—malignant glioma	6.81e-05	0.000153	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NOTCH1—malignant glioma	6.63e-05	0.000148	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BCAN—malignant glioma	6.54e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NTRK1—malignant glioma	6.49e-05	0.000145	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—malignant glioma	6.26e-05	0.00014	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP3—malignant glioma	6.04e-05	0.000135	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—malignant glioma	5.99e-05	0.000134	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN2B—malignant glioma	5.99e-05	0.000134	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTK2—malignant glioma	5.81e-05	0.00013	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HES1—malignant glioma	5.71e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NCOR1—malignant glioma	5.68e-05	0.000127	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—malignant glioma	5.63e-05	0.000126	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDGFRA—malignant glioma	5.44e-05	0.000122	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—malignant glioma	5.36e-05	0.00012	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SPP1—malignant glioma	5.28e-05	0.000118	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—IDH2—malignant glioma	5.27e-05	0.000118	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TERT—malignant glioma	5e-05	0.000112	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.95e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—malignant glioma	4.91e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDGFB—malignant glioma	4.88e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGFR1—malignant glioma	4.86e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIF1A—malignant glioma	4.78e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CAV1—malignant glioma	4.63e-05	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—malignant glioma	4.58e-05	0.000102	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—IDH1—malignant glioma	4.53e-05	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—malignant glioma	4.4e-05	9.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FN1—malignant glioma	4.4e-05	9.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SPHK1—malignant glioma	4.39e-05	9.82e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—malignant glioma	4.38e-05	9.81e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BAD—malignant glioma	4.35e-05	9.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOTCH1—malignant glioma	4.31e-05	9.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.3e-05	9.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CD80—malignant glioma	4.22e-05	9.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CG—malignant glioma	4.22e-05	9.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APC—malignant glioma	4.22e-05	9.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGF—malignant glioma	4.17e-05	9.33e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTPN11—malignant glioma	4.14e-05	9.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BRAF—malignant glioma	3.96e-05	8.87e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT2—malignant glioma	3.86e-05	8.63e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CD—malignant glioma	3.71e-05	8.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—malignant glioma	3.57e-05	7.99e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF2—malignant glioma	3.55e-05	7.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—malignant glioma	3.47e-05	7.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MDM2—malignant glioma	3.32e-05	7.43e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RAF1—malignant glioma	3.31e-05	7.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB2—malignant glioma	3.27e-05	7.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS1—malignant glioma	3.26e-05	7.29e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CB—malignant glioma	3.23e-05	7.23e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—malignant glioma	3.1e-05	6.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BCHE—malignant glioma	3.03e-05	6.78e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.99e-05	6.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—malignant glioma	2.97e-05	6.65e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—malignant glioma	2.97e-05	6.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—malignant glioma	2.81e-05	6.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTEN—malignant glioma	2.79e-05	6.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—malignant glioma	2.52e-05	5.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—malignant glioma	2.5e-05	5.59e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—malignant glioma	2.47e-05	5.54e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—malignant glioma	2.41e-05	5.39e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAT—malignant glioma	2.34e-05	5.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—malignant glioma	2.32e-05	5.19e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—malignant glioma	2.27e-05	5.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NCOR1—malignant glioma	2.21e-05	4.95e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KRAS—malignant glioma	2.14e-05	4.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—malignant glioma	1.97e-05	4.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—malignant glioma	1.9e-05	4.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAV1—malignant glioma	1.8e-05	4.04e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.64e-05	3.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—malignant glioma	1.61e-05	3.6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—malignant glioma	1.59e-05	3.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.44e-05	3.23e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.26e-05	2.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—malignant glioma	1.25e-05	2.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTEN—malignant glioma	1.09e-05	2.44e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.68e-06	1.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—malignant glioma	6.27e-06	1.4e-05	CbGpPWpGaD
